Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 02 Jan 2026 for Janux Therapeutics, Inc., €32k. Read the official filing
Filing timeline
BuySaleZachariah McIver
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Zachariah McIver: trading record in brief
This profile gathers the share dealings of Zachariah McIver in Janux Therapeutics, Inc. Over a trading history stretching from 2 January 2025 to 2 January 2026, the count stands at 2 filings.
No open-market purchase appears, only 1 sale worth €32k. The rest of the record consists of 1 share grant. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 2 January 2026 with an open-market sale (€32k) in Janux Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Zachariah McIver
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
2,714 shares@ US$13.73Common StockSEC:0002050056-26-000002:0
26,000 shares0Common StockSEC:0001415889-25-000677:0
2 of 2 declarations
